Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dona Blanca was an Australian unlisted medical cannabis company with cultivation and extraction operations in Colombia. The company focused on producing pharmaceutical-grade cannabis products and derivatives, including full-spectrum cannabis oil, using GACP cultivation standards and an EU-GMP-oriented extraction strategy. Its business model emphasized low-cost cultivation in Colombia and export into international medical cannabis markets, particularly Europe and other regulated jurisdictions. Dona Blanca operated through its Colombian subsidiary Extractos Dona Blanca S.A.S. and also referenced a joint venture with Medcolcanna Organics. Publicly available records indicate the Australian entity's ABN status was cancelled on May 22, 2025, suggesting the company is no longer active as an operating corporate entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dona Blanca.